Timber Creek Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-30
Closed -$4.6K – 133
2022
Q3
$4K Hold
30
– – ﹤0.01% 127
2022
Q2
$4K Sell
30
-30
-50% -$4.58K ﹤0.01% 122
2022
Q1
$9K Hold
60
– – ﹤0.01% 112
2021
Q4
$8K Hold
60
– – ﹤0.01% 106
2021
Q3
$6K Sell
60
-110
-65% -$12.6K ﹤0.01% 115
2021
Q2
$19K Sell
170
-60
-26% -$6.76K 0.01% 103
2021
Q1
$24K Sell
230
-60
-21% -$6.42K 0.01% 94
2020
Q4
$31K Hold
290
– – 0.01% 85
2020
Q3
$25K Hold
290
– – 0.01% 86
2020
Q2
$28K Sell
290
-100
-26% -$8.8K 0.02% 78
2020
Q1
$29K Sell
390
-100
-20% -$8.52K 0.02% 85
2019
Q4
$43K Hold
490
– – 0.03% 84
2019
Q3
$37K Hold
490
– – 0.02% 86
2019
Q2
$35K Hold
490
– – 0.02% 87
2019
Q1
$39K Hold
490
– – 0.03% 83
2018
Q4
$45K Buy
490
+110
+29% +$9.67K 0.04% 78
2018
Q3
$35K Hold
380
– – 0.02% 83
2018
Q2
$35K Hold
380
– – 0.02% 86
2018
Q1
$35K Sell
380
-20
-5% -$2.2K 0.02% 87
2017
Q4
$38K Hold
400
– – 0.02% 88
2017
Q3
$35K Hold
400
– – 0.02% 90
2017
Q2
$29K Hold
400
– – 0.02% 92
2017
Q1
$26K Hold
400
– – 0.02% 86
2016
Q4
$25K Hold
400
– – 0.02% 93
2016
Q3
$25K Buy
+400
New +$25.9K 0.02% 90
2016
Q1
– Sell
-212
Closed -$12K – 94
2015
Q4
$12K Hold
212
– – 0.01% 87
2015
Q3
$11K Buy
212
+87
+70% +$5.66K 0.01% 84
2015
Q2
$8K Hold
125
– – 0.01% 88
2015
Q1
$7K Hold
125
– – 0.01% 88
2014
Q4
$9K Hold
125
– – 0.01% 83
2014
Q3
$7K Hold
125
– – 0.01% 84
2014
Q2
$7K Buy
+125
New +$6.56K 0.01% 85

Other funds holding ABBV

Timber Creek Capital Management's ABBV Position: Q4 2022 in Review

Timber Creek Capital Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 30 shares — an estimated $4.6K sold.

Timber Creek Capital Management first reported a position in ABBV in Q2 2014 and held it in 32 quarters. The position peaked at $45K in Q4 2018. 3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Timber Creek Capital Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Timber Creek Capital Management sold 30 AbbVie shares in Q4 2022, an estimated $4.6K.
  • Timber Creek Capital Management first reported a position in AbbVie in Q2 2014 and held it in 32 quarters.
  • Timber Creek Capital Management's AbbVie position peaked at $45K in Q4 2018.
  • 3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Timber Creek Capital Management's 13F filing for Q4 2022, filed 23 Jan 2023.